Capital Fund Management (CFM)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.1M | Sell |
53,145
-28,153
| -35% | -$4.84M | 0.04% | 586 |
|
|
2026
Q1 | $13.7M | Sell |
81,298
-52,603
| -39% | -$9M | 0.06% | 431 |
|
|
2025
Q4 | $22.6M | Buy |
+133,901
| New | +$21.7M | 0.06% | 441 |
|
|
2025
Q3 | – | Sell |
-92,567
| Closed | -$12.6M | – | 2560 |
|
|
2025
Q2 | $11.7M | Sell |
92,567
-48,619
| -34% | -$5.97M | 0.03% | 668 |
|
|
2025
Q1 | $18.1M | Buy |
141,186
+23,912
| +20% | +$3.24M | 0.05% | 476 |
|
|
2024
Q4 | $15.5M | Buy |
+117,274
| New | +$16.5M | 0.04% | 564 |
|
|
2023
Q4 | – | Sell |
-61,101
| Closed | -$7.45M | – | 2198 |
|
|
2023
Q3 | $7.47M | Buy |
+61,101
| New | +$7.77M | 0.03% | 745 |
|
|
2023
Q1 | – | Sell |
-34,581
| Closed | -$4.53M | – | 1647 |
|
|
2022
Q4 | $4.54M | Buy |
34,581
+16,253
| +89% | +$2.1M | 0.03% | 647 |
|
|
2022
Q3 | $2.14M | Buy |
18,328
+7,650
| +72% | +$950K | 0.02% | 843 |
|
|
2022
Q2 | $1.26M | Buy |
+10,678
| New | +$1.27M | 0.01% | 988 |
|
|
2021
Q4 | – | Sell |
-17,107
| Closed | -$2.65M | – | 1712 |
|
|
2021
Q3 | $2.77M | Hold |
17,107
| – | – | 0.02% | 795 |
|
|
2021
Q2 | $2.8M | Buy |
+17,107
| New | +$2.64M | 0.02% | 800 |
|
|
2020
Q4 | – | Sell |
-45,251
| Closed | -$6.47M | – | 1408 |
|
|
2020
Q3 | $6.13M | Buy |
+45,251
| New | +$6.14M | 0.08% | 296 |
|
|
2019
Q3 | – | Sell |
-28,616
| Closed | -$3.12M | – | 1765 |
|
|
2019
Q2 | $3.12M | Buy |
+28,616
| New | +$3.04M | 0.03% | 667 |
|
|
2018
Q2 | – | Sell |
-5,083
| Closed | -$544K | – | 2113 |
|
|
2018
Q1 | $543K | Sell |
5,083
-6,372
| -56% | -$706K | ﹤0.01% | 1433 |
|
|
2017
Q4 | $1.22M | Buy |
+11,455
| New | +$1.22M | 0.01% | 1143 |
|
|
2017
Q3 | – | Sell |
-103,551
| Closed | -$11.1M | – | 1620 |
|
|
2017
Q2 | $10.7M | Buy |
103,551
+48,354
| +88% | +$4.76M | 0.09% | 286 |
|
|
2017
Q1 | $5.4M | Buy |
55,197
+5,391
| +11% | +$516K | 0.05% | 445 |
|
|
2016
Q4 | $4.41M | Buy |
+49,806
| New | +$4.53M | 0.04% | 533 |
|
|
2016
Q3 | – | Sell |
-24,006
| Closed | -$2.28M | – | 1669 |
|
|
2016
Q2 | $2.06M | Buy |
+24,006
| New | +$2.15M | 0.02% | 725 |
|
|
2015
Q4 | – | Sell |
-85,200
| Closed | -$9.25M | – | 1634 |
|
|
2015
Q3 | $8.62M | Buy |
+85,200
| New | +$10.2M | 0.1% | 270 |
|
|
2015
Q2 | – | Sell |
-32,433
| Closed | -$3.88M | – | 1567 |
|
|
2015
Q1 | $3.71M | Buy |
32,433
+14,001
| +76% | +$1.54M | 0.05% | 422 |
|
|
2014
Q4 | $1.86M | Sell |
18,432
-6,624
| -26% | -$644K | 0.02% | 698 |
|
|
2014
Q3 | $2.29M | Buy |
+25,056
| New | +$2.2M | 0.03% | 636 |
|
Other funds holding IBB
CB
Capital Fund Management (CFM)'s IBB Position: Q2 2026 in Review
Capital Fund Management (CFM) reduced its iShares Biotechnology ETF (IBB) stake by 35% in Q2 2026, selling an estimated $4.84M and leaving 53,145 shares worth $10.1M. The position accounts for 0.04% of the portfolio, ranked #586.
Capital Fund Management (CFM) first reported a position in IBB in Q3 2014 and has held it in 24 quarters since. The position peaked at $22.6M in Q4 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Capital Fund Management (CFM) held 53,145 shares of iShares Biotechnology ETF worth $10.1M as of Q2 2026.
- Capital Fund Management (CFM) sold 28,153 iShares Biotechnology ETF shares in Q2 2026, an estimated $4.84M.
- iShares Biotechnology ETF made up 0.04% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #586 holding.
- Capital Fund Management (CFM) first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 24 quarters since.
- Capital Fund Management (CFM)'s iShares Biotechnology ETF position peaked at $22.6M in Q4 2025.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.